SCHEMBL18196934

SCHEMBL18196934

CNCc1cn(S(=O)(=O)c2ccc(F)c(F)c2)c(-c2c(F)cccc2F)c1OC

nearest known ligand 0.41

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ALDH3A1 P30838 2/20 0.41
▸ HTR6 P50406 10/20 0.40
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ GLRA3 O75311 1/20 0.32
▸ GLRB P48167 1/20 0.32
▸ TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL20530222 0.99 ALDH3A1 (0.40) ALDH3A1HTR6KMT2ASMN1; SMN2ALDH1A1
SCHEMBL18196886 0.92 ALDH3A1 (0.38) ALDH3A1HTR6KMT2ASMN1; SMN2ALDH1A1
SCHEMBL18196911 0.91 MAPT (0.39) HTR6KMT2ASMN1; SMN2ALDH1A1MAPT
Hydrochloric Acid SCHEMBL18190940 0.91 ALDH3A1 (0.38) ALDH3A1HTR6KMT2ASMN1; SMN2ALDH1A1
Hydrochloric Acid SCHEMBL20530177 0.90 MAPT (0.38) HTR6KMT2ASMN1; SMN2ALDH1A1MAPT
SCHEMBL18190928 0.90 HTR6 (0.43) HTR6KMT2AALDH1A1KDM4EPOLB
SCHEMBL18196919 0.90 HTR6 (0.40) HTR6KMT2ASMN1; SMN2MAPTKDM4E
Hydrochloric Acid SCHEMBL20530183 0.89 HTR6 (0.42) HTR6KMT2AALDH1A1KDM4EPOLB
Hydrochloric Acid SCHEMBL20530215 0.89 HTR6 (0.39) HTR6KMT2ASMN1; SMN2MAPTKDM4E
SCHEMBL18190930 0.89 LMNA (0.43) HTR6ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP claimed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US claimed
EP-3197867-B1 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAE WOONG PHARMA (KR) 2018-11-14 — — EP disclosed
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2018-10-16 — — US disclosed
WO-2016175555-A2 NOVEL 4-METHOXY PYRROLE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-11-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10100010-B1 4-methoxy pyrrole derivatives or salts thereof and pharmaceutical composition comprising the same GIPR, GRPR, HTR3E ALDH3A1 2418/4885HTR6 38/4885KMT2A 3645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback